Home » Stocks » ClearPoint Neuro

ClearPoint Neuro Inc. (CLPT)

Stock Price: $7.24 USD -0.06 (-0.82%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $7.29 +0.05 (0.69%) Oct 23, 4:42 PM

Stock Price Chart

Key Info

Market Cap 113.90M
Revenue (ttm) 11.73M
Net Income (ttm) -6.48M
Shares Out 15.73M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $7.24
Previous Close $7.30
Change ($) -0.06
Change (%) -0.82%
Day's Open 7.24
Day's Range 7.16 - 7.38
Day's Volume 63,046
52-Week Range 2.86 - 8.91

More Stats

Market Cap 113.90M
Enterprise Value 115.91M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 15.73M
Float 11.54M
EPS (basic) -0.42
EPS (diluted) -0.42
FCF / Share -0.38
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 68,769
Short Ratio 0.66
Short % of Float 0.60%
Beta 0.77
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9.71
PB Ratio 85.71
Revenue 11.73M
Operating Income -5.01M
Net Income -6.48M
Free Cash Flow -5.92M
Net Cash -2.02M
Net Cash / Share -0.13
Gross Margin 62.94%
Operating Margin -42.72%
Profit Margin -55.30%
FCF Margin -50.46%
ROA -17.26%
ROE -157.26%
ROIC -41.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.50*
(45.03% upside)
Low
8.00
Current: $7.24
High
13.00
Target: 10.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue11.227.357.385.754.593.603.935.063.822.67
Revenue Growth52.54%-0.36%28.35%25.15%27.46%-8.3%-22.29%32.48%43.03%-
Gross Profit7.384.924.483.112.611.682.514.503.162.65
Operating Income-4.59-5.25-6.34-7.49-8.97-5.32-7.47-3.13-5.92-9.52
Net Income-5.54-6.16-7.17-8.07-8.45-4.52-7.09-5.88-8.31-9.45
Shares Outstanding13.1610.937.742.751.881.481.431.010.400.17
Earnings Per Share-0.42-0.56-0.93-2.93-4.48-3.06-4.80-6.00-20.80-56.00
Operating Cash Flow-2.85-4.63-5.99-5.82-8.64-7.25-7.78-7.43-6.24-7.71
Capital Expenditures-0.16-0.06-0.03-0.10-0.08-0.05-0.07-0.13-0.03-0.06
Free Cash Flow-3.01-4.69-6.02-5.92-8.71-7.30-7.85-7.56-6.27-7.77
Cash & Equivalents5.703.109.293.325.419.243.521.620.15-
Total Debt2.463.484.924.497.957.698.426.5314.43-
Net Cash / Debt3.23-0.384.37-1.18-2.541.55-4.91-4.91-14.29-
Assets11.937.8613.907.409.9413.397.875.553.03-
Liabilities7.346.358.078.1611.9213.4914.7113.4224.87-
Book Value4.591.515.83-0.76-1.98-0.10-6.83-7.87-21.84-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ClearPoint Neuro Inc.
Country United States
Employees 49
CEO Joseph Michael Burnett

Stock Information

Ticker Symbol CLPT
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: CLPT

Description

ClearPoint Neuro operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.